Covalent organic frameworks with imine proton acceptors for efficient photocatalytic H 2 production

Covalent organic frameworks (COFs) are promising crystalline materials for the light-driven hydrogen evolution reaction (HER) due to their tunable chemical structures and energy band gaps. However, deeply understanding corresponding mechanism is still challenging due to the multiple components and complicated electron transfer and reduction paths involved in photocatalytic HER. Here, the photocat-alytic HER investigation has been reported based on three COFs catalysts, 1 -3 , which are prepared by benzo[1,2-b :3,4-b ':5,6-b']trithiophene-2,5,8-trialdehyde to react with C 3 symmetric triamines including tris(4-aminophenyl)amine, 1,3,5-tris(4-aminophenyl)benzene, and (1,3,5-tris-(4-aminophenyl)triazine, re-spectively. As the isostructural hexagonal honeycomb-type COF of 2 and 3 reported previously, the crystal structure of 1 has been carefully correlated through the powder X-ray diffraction study with the help of theoretical simulations. 1 shows highly porous framework with Brunauer-Emmett-Teller surface area of 1249 m2/g. Moreover, the introduction of ascorbic acid into the photocatalytic system of COFs achieves the hydrogen evolution rate of 3.75, 12.16 and 20.2 mmol g -1 h -1 for 1 -3 , respectively. The important role of ascorbic acid in photocatalysis of HER is disclosed to protonate the imine linkages of these COFs, leading to the obvious absorbance red-shift and the improved charge separation efficiency together with reduced resistance in contrast to pristine materials according to the spectroscopic and electronic charac-terizations. These innovations of chemical and physical properties for these COFs are responsible for their excellent photocatalytic performance. These results elucidate that tiny modifications of COFs structures is able to greatly tune their band structures as well as catalytic properties, therefore providing an available approach for optimizing COFs functionalities. (c) 2023 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.